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Background: In a previous study, we showed that a saponin mixture isolated from the roots of Ampelozizyphus
amazonicus Ducke (SAPAaD) reduces urine excretion in rats that were given an oral loading of 0.9 % NaCl (4 ml/100 g
body weight). In the present study, we investigated whether atrial natriuretic peptides (ANP) and renal ATPases play a
role in the SAPAaD- induced antidiuresis in rats.
Methods: To evaluate the effect of SAPAaD on furosemide-induced diuresis, Wistar rats (250-300 g) were given an oral
loading of physiological solution (0.9 % NaCl, 4 ml/100 g body weight) to impose a uniform water and salt state. The
solution containing furosemide (Furo, 13 mg/kg) was given 30 min after rats were orally treated with 50 mg/kg SAPAaD
(SAPAaD+ Furo) or 0.5 ml of 0.9 % NaCl (NaCl + Furo). In the SAPAaD+NaCl group, rats were pretreated with SAPAaD
and 30 min later they received the oral loading of physiological solution. Animals were individually housed in
metabolic cages, and urine volume was measured every 30 min throughout the experiment (3 h). To investigate the
role of ANP and renal Na+ pumps on antidiuretic effects promoted by SAPAaD, rats were given the physiological
solution (as above) containing SAPAaD (50 mg/kg). After 90 min, samples of urine and blood from the last 30 min were
collected. Kidneys and atria were also removed after previous anesthesia. ANP was measured by radioimmunoassay
(RIA) and renal cortical activities of Na+- and (Na+,K+)-ATPases were calculated from the difference between the [32P] Pi
released in the absence and presence of 1 mM furosemide/2 mM ouabain and in the absence and presence of 1 mM
ouabain, respectively.
Results: It was observed that SAPAaD inhibited furosemide-induced diuresis (at 90 min: from 10.0 ± 1.0 mL, NaCl + Furo
group, n = 5, to 5.9 ± 1.0 mL, SAPAaD+ Furo group n= 5, p< 0.05), increased both Na+-ATPase (from 25.0 ± 5.9 nmol
Pi.mg-1.min-1, control, to 52.7 ± 8.9 nmol Pi.mg-1.min-1, p< 0.05) and (Na+,K+)-ATPase (from 47.8 ± 13.3 nmol Pi.mg-1.
min-1, control, to 79.8 ± 6.9 nmol Pi .mg-1.min-1, p< 0.05) activities in the renal cortex. SAPAaD also lowered urine ANP
(from 792 ± 132 pg/mL, control, to 299± 88 pg/mL, p< 0.01) and had no effect on plasma or atrial ANP.
Conclusion: We concluded that the SAPAaD antidiuretic effect may be due to an increase in the renal activities of Na+-
and (Na+,K+)-ATPases and/or a decrease in the renal ANP.
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Several studies have reported that some medicinal herbs
alter diuresis [1-5] even though little is known about the
mechanism(s) that account for this claimed physiological
effect. Ampelozizyphus amazonicus (A. amazonicus) is a
Rhamnaceae known as ‘saracura-mirá’ or ‘Indian beer’ that
is traditionally used by Brazilian Indians and Cabocos
(from the Tupi kaa'boc) who live in all regions along Rio
Negro, Amazônia. Beverages prepared with their roots are
used as stimulant against tiredness, fatigue and starvation
[6]). The beverage is also used against malaria, liver distur-
bances and sleeplessness, and serve as depurative [7].
In a previous studies, we have shown that a triterpene
saponin mixture isolated from the roots of A. amazonicus
Ducke (SAPAaD), reduced the urine excretion of normal
rats in a dose-dependent manner [8]. There is a need for
novel oral antidiuretics to treat diseases, such as pituitary
diabetes insipidus and nephrogenic diabetes insipidus;
however, investigations for compounds other than the typ-
ically used arginine vasopressin (AVP) or desmopressin
are lacking. It is well known that diuresis is regulated by a
number of endogenous and exogenous compounds that
act at multiple intrarenal sites to influence urine formation
[9]. The final urine volume and composition are deter-
mined primarily in the renal tubule system without a dir-
ect extensive dependence on the glomerular filtration rate.
In the renal tubules, water reabsorption is usually second-
ary to transcellular sodium reabsorption. Additionally,
AVP regulates water balance and osmolality by manipulat-
ing water permeability that is not obscured by responses
to sodium reabsorption [10]. Renal tubular sodium re-
absorption involves two primary active transporters: the
ouabain-sensitive (Na+,K+)-ATPase and the furosemide-
sensitive Na+-ATPase [9-11]. The activity of both ATPases
is directly regulated by hormones, such as natriuretic pep-
tides. These hormones play an important role in hydro-
electrolytic homeostasis by stimulating natriuresis through
the coordination of apical sodium channels and basolat-
eral (Na+,K+)-ATPases in the inner medullary collecting
ducts [12-16]. Over the last few decades, several studies
have demonstrated the potential role of the cortical so-
dium pumps in the composition of excreted urine. The
various hormones that play a role in the modulation of
urine composition act on these sodium pumps in the cor-
tical segment, particularly in the proximal tubule [17-19].
Accordingly, it is well known that specific modifications
of sodium reabsorption in the proximal tubule cells lead
to an increase in renal sodium and water excretion as
observed in primary hypertension [20-23]. Then, it is
plausible to postulate that changes in the cortical sodium
pumps promoted by a compound could lead to changes
in urine composition. It has been reported that sodium
pumps’ activities can be modulated by herbal products,
such as Petroselinum hortense extracts, which inhibit (Na+,K+)-ATPase, and saponins isolated from Costus spicatus
Swartz, which inhibit Na+-ATPase activity [24,25]. Because
the inhibition of renal Na+ transport may account for the
diuretic effect of different agents, we investigated the renal




The roots of A. amazonicus Ducke were collected (Sep-
tember, 2000) in the city of Presidente Figueiredo, Ama-
zonas State, Brazil, and were identified by Dr. Ari
Hidalgo. Voucher specimens (189,858) were deposited in
the herbarium of the Instituto Nacional de Pesquisa da
Amazônia (Manaus/AM, Brazil).
Extraction, isolation and characterization of SAPAaD
The extraction, isolation and chemical characterization of
SAPAaD were performed according to previously
described procedures [8]. Powdered roots of A. amazoni-
cus were successively extracted by percolation with 70 %
ethanol, with the solvent then evaporated to dryness
(6.6 % w/w). The crude extract was resuspended in water
and treated with n-butanol. After evaporation at a max-
imum of 60°C, the organic and aqueous phases furnished
the SAPAaD and saponin-free (SAPAaD-free) fractions,
respectively. Chemical characterisation was performed by
HPLC/DAD. Briefly, HPLC analysis was carried out on an
Agilent 1200 system (Palo Alto, CA, USA). Column,
lichrospher reversed-phase C18 (250 mm x 4.6 mm I.D.,
5 μm particle size, Merck); mobile phase, acetonitrile
(solvent A) and water (solvent B); elution gradient,
30–40 % A at 0–10 min, 40–90 % A at 10–40 min,
90–100 % A at 40–45 min, and 100 % A at 45–50 min;
flow rate, 1.0 mL/min; injection volume, 20 μL. For the
analysis, 30 mg of SAPAaD were dissolved in 10 mL of
acetonitrile:water (30:70) in an ultrasonic bath for 10 min.
All solutions were filtered through a 0.45 μm membrane
filter before injection. UV photodiode array detection was
performed at 205 nm, and UV spectra from 200 to 400 nm
were on-line recorded for peak identification.
Animals
Male Wistar rats weighing 250–300 g were housed in
standard conditions with free access to commercial
chow and water prior to the experiment. Animals were
kept at a room temperature of 22°C with a light/dark
cycle of 14/10 h. All procedures described here had
prior approval from the Institutional Animal Use Ethics
Committee (protocol 177, November, 2008).
Interaction between furosemide and SAPAaD
To evaluate a possible interaction between furosemide
(LasixW, Aventis Pharma Ltda, São Paulo, Brazil) and
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physiological solution (0.9 % NaCl, 4 ml/100 g body
weight) to impose a uniform water and salt state. The
physiological solution containing furosemide (13 mg/kg)
was given 30 min after rats were orally treated with
50 mg/kg SAPAaD (SAPAaD+Furo group) or 0.5 ml of
0.9 % NaCl (NaCl + Furo group). Rats of group
SAPAaD+NaCl were pretreated with SAPAaD and
30 min later they received the oral loading of physio-
logical solution. Rats in the NaCl +AVP group received
the physiological solution containing 200 ng/kg AVP
(Sigma Chemical Co., St Louis, MO, USA, 98 % purity)
after (30 min) rats were orally treated with 0.5 ml of
0.9 % NaCl. Rats in the NaCl +NaCl group received the
oral loading of physiological solution after pretreatment
with 0.5 ml of 0.9 % NaCl (control). Animals were indi-
vidually housed in metabolic cages, and urine volume
was measured every 30 min throughout the experiment
(3 h).
In a series of experiments, rats were given the oral load-
ing of physiological solution as above in the absence (con-
trol) and presence of 50 mg/kg SAPAaD. At 90 min after
SAPAaD administration, the urine volume was measured,
and a sample of urine was collected and stored at −20°C
until the measurement of urine ANP was performed.
Afterward, the rats were anesthetized with 40 mg/kg of
thiopental, and a blood sample was drawn from the infer-
ior cava vein. Under anesthesia, the rats were sacrificed,
and the kidneys were removed for the histomorphological
analysis and the renal ATPase activity measurements. Both
atria were also removed to determine the ANP content.
Blood samples were centrifuged at 3,000 rpm for 10 min
at 4°C, and the recovered plasma was stored at −80°C until
the ANP assay was performed. For the histomorphological
analysis, sections of the kidney were obtained from repre-
sentative animals in the control and SAPAaD-treated
groups. The tissue was fixed in 10 % formalin, embedded
in paraffin and was dissected into 4 μm sections. The sec-
tions were stained with hematoxylin and eosin and were
examined under a light microscope.
Measurement of renal ATPases’ activities
The kidneys were removed immediately after the rats
were sacrificed under anesthesia and were maintained in
a cold isosmotic solution containing 250 mM sucrose,
10 mM HEPES-Tris, pH 7.6, 2 mM ethylenediaminete-
traacetic acid (EDTA) and 1 mM phenylmethylsulfonyl
fluoride (PMSF). Thin slices of cortex (cortex-corticis)
were separated using a scalpel and homogenized in the
same cold solution with a teflon and glass homogenizer.
The homogenate was centrifuged for 10 min at
10,000 rpm in a Sorvall centrifuge using an SS-34 rotor
at 4°C. The pellet was discarded and the supernatant was
centrifuged for 1 h at 60,000 rpm at 4°C. The membranepellet containing the microsomal fraction was resus-
pended in 250 mM sucrose to a final concentration of
6–10 mg of protein per milliliter and was stored at 4°C.
ATPase activity was measured as previously reported
[26-28]. Na+-ATPase and (Na+,K+)-ATPase activities
expressed in nmol Pi x mg-1 x min-1 were obtained by
subtracting the enzyme activity in the absence and pres-
ence of furosemide (2 mM) and ouabain (1 mM), re-
spectively [27,28].
Measurement of atrial natriuretic peptides
To determine the atrial content of ANP, the left and
right atria were pooled in a prechilled tube containing
a cocktail of protease inhibitors consisting of 0.1 M
acetic acid, 10-5 mol/L EDTA, 10-5 mol/L PMSF and
0.5 x 10-5 mol/L pepstatin A (Sigma Chemical Co.,
St. Louis, MO, USA). The tube contents were homogenized
(Euroturrax homogenizer T20b; Janke and Kunkel Ika
Labortechnik, Staufen, Germany) and centrifuged at 20,000
x g for 30 min at 4°C. The supernatants were diluted in a
phosphosaline buffer (0.01 mol/L sodium phosphate,
0.14 mmol/L bovine serum albumin, 0.10 % Triton X-100,
0.10 mol/L NaCl and 0.01 % sodium azide, pH 7.4), and
ANP content was determined by radioimmunoassay (RIA)
[29]. ANP antibody was kindly donated by Dr. J Gutkowska
(CHUM – Université de Montreal, Montreal, Canada).
Standard ANP was obtained from Bachem Inc. (Torrance,
CA, USA). The protein concentration in the supernatant
was measured as previously described [30]. Atrial ANP was
normalized to protein concentration and reported in micro-
grams per milligram of protein. To quantify plasma ANP,
plasma samples (1 mL) were extracted in Sep-Pak C18 car-
tridges (Waters Corporation, Milford, MA, USA). Eluents
were evaporated until dry in a Speed-Vac (Eppendorf 5301,
Hamburg, Germany), and the resultant powder was dis-
solved in 500 μL of phosphosaline buffer prior to determin-
ing the ANP concentration by RIA [29]. To quantify the
urine ANP, 1 mL of urine was extracted using Sep-Pak C18
cartridges (Waters Corporation, Milford, MA, USA), as pre-
viously described [29]. After being evaporated until dry in a
Speed-Vac, the samples were dissolved in 500 μL of phos-
phosaline buffer, and urine ANP was determined by RIA
using anti-ANP antibodies. Because atrial ANP and urine
ANP have a very similar structure with an identical C-
terminus [31], anti-ANP antibodies may also be employed
to measure ANP in urine. In addition, insignificant concen-
trations of circulating ANP are found in the urine because
of high ANP degradation from peptidases in the kidney cor-
tex membranes or because of ANP binding to the clearance
C receptor [32,33].
Statistical analysis
The results were expressed as means ± standard error of
the mean (± SEM). The data shown the effect of
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nonlinear regression and two-way ANOVA followed by
Bonferroni’s test. To analyze the other investigated para-
meters, unpaired Student’s t-test was also employed to
compare the control and SAPAaD-treated groups. A p-
value less than 0.05 (p< 0.05) was considered statistically
significant.
Results
Figure 1 shows a typical fingerprint chromatogram of
SAPAaD mixture. The retention times of saponins were
between 9.42 and 16.78 min. The purification process
performed to obtain saponins was very efficient since the
peaks related to saponins were predominant in the
SAPAaD fraction fingerprint.
All experiments using animals were performed in rats
with a 4 % body weight volume expansion (oral loading
of 0.9 % NaCl, 4 ml/100 g body weight) because this
magnitude of volume expansion is an intermediate value
between the experimentally obtainable minimum and
maximum values used for studies examining the acute
effect of substances that either stimulate or inhibit diur-
esis. In this study, SAPAaD was tested at the dose of
50 mg/kg because it resulted in an approximate 60 % re-
duction in the diuresis induced by the oral loading of
0.9 % NaCl (4 ml/100 g body weight) in normal rats.
This reduction was reported in our previous study [8] in
which we have shown that SAPAaD at dose varying from
25 to 1000 mg/kg reduced the urine production in a
dose-dependent manner. As 60 % reduction neither rep-
resent the minimum nor the maximum effect of
SAPAaD, 50 mg/kg was the dose of choice to perform
the experiments in the present study. No significant al-
teration of renal morphology was observed after
SAPAaD treatment (data not shown).
Interaction between furosemide and SAPAaD
As shown in Figure 2, SAPAaD and furosemide have an-
tagonistic effects on diuresis. While SAPAaD reducedFigure 1 HPLC fingerprinting of SAPAaD. The retention times of
saponins are (in min): 1–9.42, 2–9.85, 3–11.32, 4–13.46, 5–13.79, 6–
14.75 and 7–16.78. Detection, 205 nm; mAU, milli absorbance unit.the diuresis elicited by the oral loading of 0.9 % NaCl
(at 180 min: from 8.5 ± 1.0 mL, NaCl +NaCl group, to
4.0 ± 1.3 mL, SAPAaD+NaCl group, n = 5) (Figure 2A),
furosemide dosed at 13 mg/kg greatly increased urine
elimination in rats that equally received oral 0.9 % NaCl
(at 180 min: from 8.5 ± 1.0 mL to 12.2 ± 1.4 mL, NaCl +
Furo group, n = 5) (Figure 2A). However, pretreatment
with SAPAaD eliminates this increase in the furosem-
ide-induced diuresis (Figure 2B). In the presence of
SAPAaD, the urine volume produced by furosemide
(8.5 ± 1.3 mL, SAPAaD+ Furo group n = 5) (Figure 2B)
was similar to that observed in the NaCl +NaCl group
(8.5 ± 1.0 mL, n = 5) (Figure 2A) at 180 min. It is note-
worthy that SAPAaD, although in a less extent, induced
antidiuresis as AVP, which was used as a positive con-
trol (Figure 2B).
Effect of SAPAaD on renal ATPases’ activities and atrial
natriuretic peptides
SAPAaD (50 mg/kg) significantly increased the activities
of renal Na+-ATPase (from 25.0 ± 5.9 nmol Pi. mg-1.
min-1, control, n = 4, to 52.7 ± 8.9 nmol Pi.mg-1. min-1,
n = 4, p< 0.05) (Figure 3A) and renal (Na+, K+)-ATPase
(from 47.8 ± 13.3 nmol Pi.mg-1.min-1, control, n = 4, to
79.8 ± 6.9 nmol Pi.mg-1.min-1, n = 4, p< 0.05) (Figure 3B).
The ANP levels in both the plasma (Figure 4A, n = 6)
and atria (Figure 4B, n = 6) were not significantly affected
by SAPAaD at the 50 mg/kg dosage. In contrast, urine
ANP excretion was significantly reduced in the rats trea-
ted with SAPAaD (from 792 ± 132 pg/mL, control, n = 7,
to 299 ± 88 pg/mL, n = 7, p< 0.01) (Figue 4C).
Discussion
In this study, we showed for the first time that saponins,
in vivo, stimulate renal ATPases and reduce the level of
urine ANP. These effects are undoubtedly characteristic
of an antidiuretic agent. Moreover, SAPAaD abolished
the diuretic effect of furosemide, a classical diuretic that
affects renal Na+-ATPases [32]. In a previous study, our
group reported that the oral administration of SAPAaD
exhibited a dose-dependent antidiuretic effect in normal
rats in either dehydrated or hydrated conditions [8]. In
the present study, SAPAaD exhibited a similar effect
even when administered 30 min prior to an oral loading
of physiological solution (0.9 % NaCl). Because pretreat-
ment with SAPAaD prevented the effect of furosemide,
one could expect that SAPAaD might share the same
mechanistic pathway by which furosemide enhances di-
uresis. According to Becker et al. [34], the diuretic effect
of furosemide was reduced in hypertensive patients with
domiciliary use of a nutritional supplement derived from
ginseng. Ginseng is a natural compound that is rich in
triterpene saponins structurally similar to SAPAaD. It is
known that furosemide inhibits renal Na+-ATPase


























































Figure 2 Effect of SAPAaD and furosemide on diuresis in rats. Animals were given an oral loading of physiological solution (0.9 % NaCl, 4 ml/
100 g body weight) to impose a uniform water and salt state. In A: Rats were orally pretreated (30 min) with 0.5 ml 0.9 % NaCl and received the
physiological solution alone (NaCl +NaCl) or containing 13 mg/kg furosemide (NaCl + Furo); SAPAaD+NaCl, rats were orally pretreated with
50 mg/kg SAPAaD and received the physiological solution alone. In B: Rats were orally pretreated with SAPAaD and received the physiological
solution containing furosemide (SAPAaD+ Furo); NaCl + AVP, rats were orally pretreated with 0.5 ml 0.9 % NaCl and received the physiological
solution containing AVP. NaCl + Furo is the same as in A. Animals (n = 5/group) were individually housed in metabolic cages, and urine volume
was measured every 30 min throughout the experiment (3 h). Data are expressed as means ± SEM. In A, *p< 0.05 vs. group NaCl +NaCl. In B,*p
<0.05, **p< 0.01 and ***p< 0.001 vs. group NaCl + Furo at the correspondent time. Data were analyzed by two-way ANOVA followed by
Bonferroni’s test.
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that the activities of renal ATPases may be modulated by
medicinal plants. It has been shown that the diuretic ef-
fect of crude Petroselinum hortense extract is accompan-
ied by the inhibition of (Na+,K+)-ATPase activity [25].
Na+-ATPase was similarly inhibited by steroidal saponins
isolated from Costus spicatus, a plant used in Brazilian
folk medicine to expel kidney stones [24]. In contrast,
the present study shows SAPAaD in vivo produced a sig-
nificant increase in both Na+- and (Na+,K+)-ATPase ac-
tivities. These data suggest that SAPAaD decreased the
diuresis, at least in part, by stimulating renal ATPases.
Accordingly, it was previously reported that saponins un-
mask a latent intracellular pool of (Na+,K+)-ATPase lead-
ing to an increase in the renal tubular ATPase activity
[35,36]. It has been reported that endogenous com-
pounds, such as ANP99-126 and urodilatin [12-14], stimu-
late natriuresis and diuresis primarily by coordinating





























Figure 3 Effect of SAPAaD on renal Na+- (A) and (Na+, K+)-ATPase acti
(0.9 % NaCl, 4 ml/100 g body weight) in the absence (control) and presenc
were sacrificed, and the kidneys were removed for renal cortical ATPase me
of total protein per minute. Data are expressed as means ± SEM of four rats
Student’s t-test.(Na+,K+)-ATPases in the inner medullary collecting
ducts [12]. However, a possible role of the cortical so-
dium pumps in the urine final composition cannot be
ruled out. Different hormones that modulate the urine
composition act on these cortical sodium pumps located
particularly in the proximal tubules [17-19]. It is well
established that specific modifications in sodium re-
absorption in proximal tubule cells lead to an increase in
renal sodium and water excretion as observed in primary
hypertension [20-23]. These observations indicate that
changes in the cortical sodium pumps may lead to
changes in urine composition. In addition, alteration in
the renal and/or plasma levels of the natriuretic peptides
may play a role in the SAPAaD-induced antidiuresis. A
significant reduction in the urine ANP concentration
was observed in the urine of rats treated with SAPAaD.
Therefore, we cannot exclude the possibility that the in-
crease in renal ATPase activity induced by SAPAaD was
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Figure 4 Effects of SAPAaD on plasma (A), atria (B) and urine (C) ANP. Rats received an oral loading of physiological solution (0.9 % NaCl,
4 ml/100 g body weight) in the absence (control) and presence of 50 mg/kg of SAPAaD). At 90 min after SAPAaD administration, a sample of
blood and urine were collected, rats were sacrificed and the atria were removed for ANP measurement. Plasma (n = 6), pooled left and right atria
(n = 6) and urine ANP (n = 7) were measured by RIA. Atria ANP were normalized to protein concentration and reported in micrograms per
milligram of protein. Data are represented as means ± SEM. ANP in control: Plasma and atria (n = 12) and urine (n = 7). **p< 0.01 compared with
the control group, unpaired Student’s t-test.
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observation that renal urodilatin inhibits Na+-ATPase ac-
tivity but not (Na+,K+)-ATPase activity in proximal
tubules [37]. However, in a previous study [38], it was
shown that exogenous urodilatin dosed at 10 nM
increased the (Na+,K+)-ATPase activity in the renal outer
cortex of Sprague–Dawley rats. The discrepancy between
this study and our investigation may be because (Na+,
K+)-ATPase activity was measured in the whole cortex
and because the urine ANP excretion was lower than the
exogenous urodilatin used in the previous study (10
nM). Natriuretic peptides are very important hormones
that regulate renal processes since they are effective at
promoting changes in renal vasculature by acting as
vasodilators, and renal tubules by reducing Na+ and
water reabsorption. In our study, the reduction in the
urine ANP may denote a decreased intrarenal ANP con-
tent. In turn, the low level of renal ANP would not
modulate the activity of renal cortical Na+ pumps result-
ing in a higher Na+ reabsorption. As a consequence, the
urinary elimination of salts and water is diminished.Conclusions
Although the precise mechanism by which SAPAaD
affect diuresis is not completely elucidated, our data indi-
cate that the antidiuretic effect of SAPAaD may be due
to a reduction in the renal ANP levels and/or an increase
in the renal ATPase activity. We also conclude that sapo-
nins from A. amazonicus Ducke might be an herbal can-
didate for an antidiuretic with therapeutic potential. On
the other hand, the A. amazonicus Ducke species should
be used with caution because antidiuretic agents should
be avoided in certain conditions, such as hypertension.Abbreviations
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